Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Very low
In children with multidrug- or rifampicin-resistant TB (MDR/RR-TB) aged below 3 years delamanid may be used as part of longer regimens.